Pharmacology and pharmacokinetics of imatinib in pediatric patients. (Record no. 27728133)

MARC details
000 -LEADER
fixed length control field 01386 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517182616.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201803s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1751-2441
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/17512433.2018.1398644
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Suttorp, Meinolf
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180301
245 00 - TITLE STATEMENT
Title Pharmacology and pharmacokinetics of imatinib in pediatric patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert review of clinical pharmacology
Date of publication, distribution, etc. Mar 2018
300 ## - PHYSICAL DESCRIPTION
Extent 219-231 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Monitoring
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Food-Drug Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fusion Proteins, bcr-abl
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imatinib Mesylate
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Myelogenous, Chronic, BCR-ABL Positive
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medication Adherence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision pharmacokinetics
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bornhäuser, Martin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Metzler, Markus
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Millot, Frédéric
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schleyer, Eberhard
773 0# - HOST ITEM ENTRY
Title Expert review of clinical pharmacology
Related parts vol. 11
-- no. 3
-- p. 219-231
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/17512433.2018.1398644">https://doi.org/10.1080/17512433.2018.1398644</a>
Public note Available from publisher's website

No items available.